Abstracts

528 – MLN4924 Reduces HIV Transcription, Cell Survival, and HIV Infectivity After Latency Reversal In Vitro

Background Neddylation is essential for post-translational regulation of many cellular processes, including transcription and protein degradation. The NEDD8-activating enzyme inhibitor MLN4924 (MLN) can block degradation of HIV restriction factor APOBEC3G (A3G) in newly infected cells. Here we show that inhibiting neddylation via MLN reduces HIV reactivation from latency after treatment with latency reversing agents (LRAs).…

573 – BACH2 Controls Seeding and Establishment of Long-Lived HIV-1 Reservoir in Memory CD4+ T Cells

Background Antiretroviral therapy (ART) is not a cure for HIV-1 infection due to the formation of latent reservoirs. Most long-lived viral reservoir cells are infected by the virus near the time of therapy initiation. A better understanding of the early events in viral reservoir seeding may help prevent latent reservoir formation. Unlike quiescent reservoir cells, CD4+CCR5+ T…

550 – TLRS Ligands and IL-15 Induce Trained Immunity in CD4 Cells and Limit HIV Infection and Persistence

Background Despite effective HIV suppression by ART, the virus persists in latent reservoirs. Our single-cell data from human and primate studies show that individuals with better HIV control and smaller reservoirs have higher interferon stimulated gene (ISG) expression in CD4+ T cells, linked to greater chromatin accessibility and transcriptional activation. ISG expression could be induced…

524 – Transcriptional Profiles of HIV RNA+ Cells in PWH on ART Differ From Those During Active Viremia

Background While HIV RNA+ cells during untreated HIV infection in people with HIV (PWH) have been characterized by scRNAseq, “transcriptionally-active” reservoir cells (HIV RNA+ cells that persist in ART-suppressed PWH) remain poorly uncharacterized. This is due in part to the inefficiency of capturing HIV transcripts using droplet-based scRNAseq analytical approaches. Methods We developed HIV-seq as…

507 – Temsavir Treatment Improves Recognition of HIV-1 Infected Cells by Broadly Neutralizing Antibodies

Background HIV-1 envelope glycoprotein (Env) is expressed on the surface of infected cells, making it an attractive target for the clearance of these cells through antibody-mediated immune activities, such as antibody-dependent cellular cytotoxicity (ADCC). It was previously demonstrated that treatment with temsavir (TMR), a small molecule, can enhance the binding of the broadly neutralizing antibody…

582 – Predominance of Non-T Follicular Helper Cell Subsets in the Lymph Node Viral Reservoir During ART

Background HIV-1 cure strategies require a comprehensive understanding of cellular phenotype of HIV tissue reservoirs for effective and selective targeting. While recent data have demonstrated the highly heterogeneous nature of peripheral blood CD4+ T cells subsets comprising the HIV reservoir of antiretroviral therapy (ART) treated people with HIV (PWH), CD4+ T follicular helper (Tfh) cells…

509 – Myeloid Targeted and Enhanced Endosomal Escapable LNPs Improve Latent HIV-1 Elimination Efficacy

Background A cure for HIV remains elusive as the excision of latent proviral DNA by adenovirus-based therapeutic systems has failed to date due to vector immunogenicity and limited targeting to viral reservoirs. In contrast, lipid nanoparticles (LNPs) are promising for targeting viral reservoirs, offering greater cargo-carrying capacity and reduced immune responses. However, limitations in endosomal…